Long-term evolution during idiopathic inflammatory myopathies;Évolution à long terme au cours des myopathies inflammatoires idiopathiques

Revue de Medecine Interne

Volumn 25, Issue SUPPL. 1, 2004, Pages

  Marie, I ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

DERMATOMYOSITIS; ELECTROMYOGRAM; HUMAN; POLYMYOSITIS; RASH; RAYNAUD PHENOMENON; REMISSION; SHORT SURVEY; IMMUNOLOGY; PROGNOSIS; REVIEW; TIME;

DERMATOMYOSITIS; HUMANS; POLYMYOSITIS; PROGNOSIS; TIME FACTORS;

EID: 2942580880     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.04.009     Document Type: Article

References (19)

1. Benbassat J., Gefel D., Larholt K., et al. Prognostic factors in polymyosites-dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. 28:1985;249-255
2. Bohan A., Peter J.B. Polymyositis and dermatomyositis: Parts I and II. N Engl J Med. 292:1975;344-347. and 403-7
3. Chow W.H., Gridley G., Mellemkjaer L., et al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 6:1995;9-13
4. Clarke A.E., Bloch D.A., Medsger T.A. Jr, et al. A longitudinal study of functional disability in a national cohort of patients with polymyosites- dermatomyositis. Arthritis Rheum. 38:1995;1218-1224
5. Dalakas M.C., Hohfeld R. Polymyositis and dermatomyositis. Lancet. 362:2003;971-982
6. Danko K., Ponyi A., Constantin T., et al. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features. A longitudinal study of 162 cases. Medicine (Baltimore). 83:2004;35-42
7. Hill C.L., Zhang Y., Sigurgeirsson B., et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 357:2001;96-100
8. Hochberg M.C., Lopez-Acuna D., Gittelsohn A.M. Mortality from following polymyositis and dermatomyositis in the United States, 1968-1978. Arthritis Rheum. 26:1983;1465-1471
9. Lilley H., Dennet X., Byrne E. Biopsy proven polymyositis in Victoria 1982-1987: analysis of prognostic factors. J Royal Soc Med. 87:1994;323-326
10. Marie I., Hachulla E., Cherin P., et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 47:2002;614-622
11. Marie I., Hachulla E., Hatron P.Y., et al. Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatol. 28:2001;2230-2238
12. Marie I., Hachulla E., Levesque H., et al. Intravenous immunoglobulins as treatment of life-threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol. 26:1999;2706-2709
13. Marie I., Hatron P.Y., Hachulla E., et al. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 25:1998;1336-1343
14. Marie I., Hatron P.Y., Levesque H., et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore). 78:1999;139-147
15. Maugars Y.M., Berthelot J.M.M., Abbas A.A., et al. Long-term prognosis of 69 patients with polymyositis or dermatomyositis. Clin Exp Rheumatol. 14:1996;263-274
16. Milller F.W. Myositis-specific autoantibodies: touch-stones for understanding the inflammatory myopathies. JAMA. 270:1993;1846-1849
17. Rose A.L., Walton J.N. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain. 89:1966;747-768
18. Sultan S.M., Ioannou Y., Moss K., et al. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 41:2002;22-26
19. Uthman I., Vazquez-Abad D., Senecal J.L. Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthritis Rheum. 26:1996;447-458